The Pharma Data

FEBRUARY 25, 2022

Several FDA-approved drugs – including for type 2 diabetes, hepatitis C and HIV – significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells, according to new research led by scientists at Penn State. 25) in the journal Communications Biology.

FDA Approval 52

FDA Approval FDA Molecular Biology Virus 52

Broad Institute

JULY 17, 2024

As of now, papers describing three of these machine learning tools have been published, in the Journal of Chemical Information and Modeling , Molecular Biology of the Cell , and Chemical Research in Toxicology. Molecular Biology of the Cell. A fourth is in the works. DOI: 10.1021/acs.chemrestox.4c00015. Seal S, et al.

Pharmacokinetics 124

Pharmacokinetics Molecular Biology Drugs FDA 124

Drug Target Review

MAY 27, 2024

At a base-layer, Caris’ comprehensive molecular profiling that we perform for patients today can identify predictive biomarkers for current FDA-approved ADCs. What role do ADCs play in Caris’ strategy for targeted cancer therapy, particularly in terms of patient-specific treatment plans?

Clinical Trials 59

Clinical Trials Science Molecular Biology Bioinformatics 59

Broad Institute

APRIL 25, 2024

The project is a collaboration between the Broad and the African Center of Excellence for Genomics of Infectious Diseases (ACEGID) at Redeemer’s University outside Lagos in Nigeria, where Happi is a professor of molecular biology and genomics.

Virus 132

Virus Hospitals Disease Government 132

Drug Target Review

AUGUST 29, 2024

MR : Chimeric antigen receptor T-cell (CAR-T) therapy is very effective in treating patients with B-cell lymphoma, leukemia, and multiple myeloma, where we have six FDA-approved drugs. What potential advantages does the CD5 modulation strategy offer over traditional CAR-T therapies?

Therapies 59

Therapies Treatment Engineering Molecular Biology 59

The Pharma Data

JANUARY 13, 2021

Vivity received FDA approval in February 2020. based Mogrify Limited expanded its research collaboration with MRC Laboratory of Molecular Biology. This presbyopia-mitigating lens is available to patients undergoing cataract surgery. Cataracts are the most common cause of vision loss globally. Mogrify – U.K.-based

Licensing 52

Licensing Licensing Clinical Trials Trials 52

The Pharma Data

JANUARY 6, 2021

Standard antibodies cannot access toxin already inside neurons, and thus BAT® (Botulism AntiToxin, a product of Emergent BioSolutions), the only FDA-approved antitoxin, is only effective while the toxin remains in the circulation.

Science 52

Science Molecular Biology Treatment Production 52